Urispas side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Urispas. Common side effects include anaemia among females, and anxiety among males.
The phase IV clinical study is created by eHealthMe based on 576 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
576 people who take Urispas and have side effects are studied.
What is Urispas?
Urispas has active ingredients of flavoxate hydrochloride. Currently, eHealthMe is studying from 583 Urispas users.
Number of Urispas reports submitted per year:
Urispas side effects by time on the drug *:
Urispas side effects by gender *:
Urispas side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Urispas?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on flavoxate hydrochloride (the active ingredients of Urispas) and Urispas (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Urispas:
- Urispas (583 reports)
Common Urispas side effects:
- High blood cholesterol: 186 reports
- Herpes zoster: 181 reports
- Joint swelling: 177 reports
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 175 reports
- Drug ineffective: 148 reports
All Urispas side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Briviact and Urocit-K drug interaction - now
- Potassium Chloride and Movement Disorder - 34 seconds ago
- Rasuvo and Stomatitis - 51 seconds ago
- Warfarin Sodium and Sodium Bicarbonate drug interaction - a minute ago
- Enoxaparin Sodium and Type I Hypersensitivity - a minute ago
- Vitamin D and Radish drug interaction - a minute ago
- Advil Liqui-Gels and Limb Injury - a minute ago
- Betaseron and Alendronic Acid drug interaction - a minute ago
- Cannabis and Skin Infection - a minute ago
- Wellbutrin and Hyperparathyroidism - a minute ago